New method for assaying free and total cholesterol in cultured cells by high-pressure liquid chromatography. 1996

K Hayashi, and Y Kuga, and Y Okura, and K Tanaka, and Y Yasunobu, and K Nomura, and Y Toyota, and H Ohtani, and T Shingu, and G Kajiyama
First Department of Internal Medicine, Hiroshima University School of Medicine, Japan.

We developed a simple, sensitive and accurate method for assaying cellular free and total cholesterol by monitoring 4-cholesten-3-one, a conversion product of the cholesterol oxidase-catalyzed oxidation of the free cholesterol that has a strong chromophoric alpha, beta-unsaturated ketone at 240 nm, using a high-pressure liquid chromatographic system. This method measured picomole quantities of free and total cholesterol and precisely determined their concentrations in cells (10(4) range) in culture using 7 beta-hydroxycholesterol as an internal standard.

UI MeSH Term Description Entries
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002783 Cholestenones CHOLESTENES with one or more double bonds and substituted by any number of keto groups.
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

K Hayashi, and Y Kuga, and Y Okura, and K Tanaka, and Y Yasunobu, and K Nomura, and Y Toyota, and H Ohtani, and T Shingu, and G Kajiyama
March 1979, Journal of chromatography,
K Hayashi, and Y Kuga, and Y Okura, and K Tanaka, and Y Yasunobu, and K Nomura, and Y Toyota, and H Ohtani, and T Shingu, and G Kajiyama
June 1981, Analytical biochemistry,
K Hayashi, and Y Kuga, and Y Okura, and K Tanaka, and Y Yasunobu, and K Nomura, and Y Toyota, and H Ohtani, and T Shingu, and G Kajiyama
June 1977, Biochemical medicine,
K Hayashi, and Y Kuga, and Y Okura, and K Tanaka, and Y Yasunobu, and K Nomura, and Y Toyota, and H Ohtani, and T Shingu, and G Kajiyama
November 1986, Journal of chromatography,
K Hayashi, and Y Kuga, and Y Okura, and K Tanaka, and Y Yasunobu, and K Nomura, and Y Toyota, and H Ohtani, and T Shingu, and G Kajiyama
January 2000, Journal of AOAC International,
K Hayashi, and Y Kuga, and Y Okura, and K Tanaka, and Y Yasunobu, and K Nomura, and Y Toyota, and H Ohtani, and T Shingu, and G Kajiyama
December 1999, Clinical chemistry,
K Hayashi, and Y Kuga, and Y Okura, and K Tanaka, and Y Yasunobu, and K Nomura, and Y Toyota, and H Ohtani, and T Shingu, and G Kajiyama
April 1976, Clinica chimica acta; international journal of clinical chemistry,
K Hayashi, and Y Kuga, and Y Okura, and K Tanaka, and Y Yasunobu, and K Nomura, and Y Toyota, and H Ohtani, and T Shingu, and G Kajiyama
October 2002, Antimicrobial agents and chemotherapy,
K Hayashi, and Y Kuga, and Y Okura, and K Tanaka, and Y Yasunobu, and K Nomura, and Y Toyota, and H Ohtani, and T Shingu, and G Kajiyama
April 1984, Pathologie-biologie,
K Hayashi, and Y Kuga, and Y Okura, and K Tanaka, and Y Yasunobu, and K Nomura, and Y Toyota, and H Ohtani, and T Shingu, and G Kajiyama
July 2015, Journal of chromatography. A,
Copied contents to your clipboard!